Related Experiment Video
Updated: Aug 15, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
A p53 growth arrest protects fibroblasts from anticancer agents
E S McCormack1, A M Bruskin, G V Borzillo
1OSI Pharmaceuticals Inc., 106 Charles Lindbergh Blvd., Uniondale, NY 11553-3649, USA. Smccormack@OSIP.com
Activating the p53 protein checkpoint through temperature changes protected cells from certain anticancer drugs. This p53-mediated chemoprotection enhanced cell survival, particularly for drugs targeting DNA synthesis or mitosis.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Cell cycle inhibitors like TGF-betas protect cells from anticancer treatments.
- The tumor suppressor protein p53 plays a crucial role in cell cycle regulation and DNA repair.
Purpose of the Study:
- To investigate if p53-induced growth arrest can provide chemoprotection against high doses of anticancer drugs.
- To determine the role of p53 mutations in cellular sensitivity to chemotherapy.
Main Methods:
- Utilized rat embryo fibroblast (REF) cell lines with varying p53 mutations.
- Induced cell cycle arrest at 31°C using temperature-sensitive p53 mutations.
- Assessed cell survival using colony-forming assays after drug exposure.
Main Results:
- Temperature-dependent p53 activation led to growth arrest at 31°C, evidenced by increased MDM2 and p21/WAF1 levels.
- p53-arrested cells demonstrated significantly enhanced survival against specific anticancer drugs compared to cells at 37°C.
- Chemoprotection was not observed with cisplatin or 5-fluorouracil, which induce cell damage irrespective of the cell cycle stage.
Conclusions:
- An activated p53 checkpoint can mediate chemoprotection, enhancing cell survival against DNA synthesis and mitosis-targeting drugs.
- p53-mediated survival mechanisms are specific and may not protect against all types of chemotherapy agents.
- This study highlights the potential of exploiting the p53 pathway for targeted chemoprotection strategies in cancer therapy.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Abnormal Proliferation
Introduction to Fibroblasts
DNA Damage Can Stall the Cell Cycle

